Science Explorer Back to mapMap
Discussion
Researcher · IDEX Corporation (United States) · United States

Carl J. Kozlosky

Carl J. Kozlosky publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as Immune Response and Inflammation, Monoclonal and Polyclonal Antibodies Research and Glycosylation and Glycoproteins Research.

OpenAlex
World rank
#730,560
of 7,710,434 ranked researchers
Rank in United States
#246,037
of 1,627,098
Works
33
Citations
8.2k
Citations per work
248.1
h-index
18
i10-index 20Top 39% in Molecular Biology
Carl J. Kozlosky

What does Carl J. Kozlosky research?

Carl J. Kozlosky's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (19%), Immunology and Microbiology (15%).

Life Sciences: 17 works · 53.0% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 32.4% of their workMolecular Biology: 9 works · 26.5% of their workCancer Research: 2 works · 5.9% of their workImmunology and Microbiology: 5 works · 14.7% of their workImmunology: 5 works · 14.7% of their workNeuroscience: 2 works · 5.9% of their workCellular and Molecular Neuroscience: 2 works · 5.9% of their workEverything else: 9 works · 27.9% of their workHealth Sciences: 6 works · 19.1% of their workMedicine: 6 works · 19.1% of their workOncology: 3 works · 10.3% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 8.8% of their workTHEIR WORKCarl J. Kozlosky33works
Life Sciences53%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1132.4%
    2. Immunology and Microbiology514.7%
    3. Neuroscience25.9%
  2. Everything else927.9%
    1. Medicine619.1%
  1. 1Molecular Biology26% of their works
  2. 2Immunology15% of their works
  3. 3Oncology10% of their works
  4. 4Radiology, Nuclear Medicine and Imaging9% of their works
  5. 5Cellular and Molecular Neuroscience6% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Carl J. Kozlosky's research?

The keywords of their largest research topics: Glycosylation, Inflammation, Cancer, Angiogenesis, Extracellular Matrix, Fc Receptors, Pattern Recognition Receptors and Therapeutic Antibodies.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Glycosylation112 topics
  2. Inflammation102 topics
  3. Cancer92 topics
  4. Angiogenesis72 topics
  5. Extracellular Matrix72 topics
  6. Fc Receptors61 topic
  7. Pattern Recognition Receptors61 topic
  8. Therapeutic Antibodies61 topic
  9. Toll-like Receptors61 topic
  10. Glycans51 topic
  11. Immune System51 topic
  12. Cell Adhesion41 topic
  13. Integrins41 topic
  14. Antimicrobial Peptides31 topic
  15. Breast Cancer31 topic
  16. HER231 topic
  17. Host Defense31 topic
  18. Matrix Metalloproteinases31 topic
  19. Tissue Inhibitors of Metalloproteinases31 topic
  20. Ribosome21 topic
  21. Translation21 topic

Where does Carl J. Kozlosky work?

Carl J. Kozlosky's main affiliation in the publication record is IDEX Corporation (United States), United States.

How many publications and citations does Carl J. Kozlosky have?

OpenAlex counts 33 works and 8,188 citations for Carl J. Kozlosky, an h-index of 18, ranking #730,560 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carl J. Kozlosky. Posts are plain text and can be reported.